Esco Lifesciences

Esco Lifesciences Group specializes in providing technology-based products and services tailored for the life sciences and healthcare sectors. The company supports a range of activities, including academic research, scientific discovery, clinical practice, and biopharmaceutical research and development. By offering innovative solutions, Esco Lifesciences aims to facilitate the invention, discovery, and commercialization of advancements in these fields, ultimately contributing to improved health and safety for individuals.

XiangQian (XQ) Lin

Chairman and CEO

Xiangliang Lin

Deputy CEO and Executive Director

Low Yae-Foong

Co-Founder, COO and Executive Director

Lim Lay Yew

Co-Founder and Executive Director

4 past transactions

Allwin Medical Devices

Corporate Round in 2025
Allwin Medical Devices is a manufacturer of a range of medical devices. They provide women’s health, IVF, urology, gastroenterology, and interventional radiology. They strive to offer quality products with integrity and utmost transparency.

MicrofluidX

Seed Round in 2022
MicrofluidX Ltd is a company focused on advancing cell bioprocessing for autologous cell and gene therapy manufacturing. Founded in 2018 and headquartered in London, United Kingdom, the company has developed an innovative microfluidic bioprocessing system that integrates various cell culture functions, including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting within a single, automated, closed system. This technology addresses challenges related to process control, scalability, and cost in cell bioprocessing, enabling biologists to efficiently conduct process development by exploring numerous cell culture conditions.

Roslin Technologies

Series A in 2022
Roslin Technologies is an ag-tech and food tech company focused on enhancing protein production through innovative biotechnologies. The company specializes in animal stem cell research, having developed perpetually self-renewing, pluripotent stem cells, which are pivotal for the advancement of cultivated meat products for consumers. Roslin's intellectual property and technological platforms are designed to supply these cell lines and related media formulations to the cultivated meat sector. Additionally, the company aims to leverage its stem cell technology to create cell therapies that address incurable diseases in animals, thereby supporting the meat industry in reducing costs and accelerating market entry.

Dongyun Medical

Corporate Round in 2021
Dongyun Medical is a research and development provider of technical medical equipment in the field of assisted reproduction. It is committed to the research and development and industrialization of special culture solutions and consumables for human assisted reproduction, and provides international-level medical products and experimental consumables.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.